Bryan Jones's most recent trade in Aardvark Therapeutics Inc. was a trade of 122,033 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Aardvark Therapeutics Inc. | Bryan Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 122,033 | 122,033 | - | - | Stock Option (right to buy) |